U.S. – FDA approves Pfizer booster shots for people over 65

Pfizer : Covid vaccine safe for kids aged 5 - 11

U.S. – FDA approves Pfizer booster shots for people over 65

The Covid-19 vaccine booster shot proposed by Pfizer Inc. and BioNTech SE should be given to a smaller group of people who are the most vulnerable to serious disease, a panel of expert advisers to the U.S. Food and Drug Administration said.

Advocates of the booster point to data that shows the Pfizer vaccine’s effectiveness against Covid-19 falls from 96% to 84% after four months. Pfizer says that a third shot brings its effectiveness back up to 95% including against the fast spreading Delta variant.

Germany, France and the Czech Republic have announced similar plans for older or vulnerable people. In Israel, boosters are already being offered to people as young as 12.